It is still unclear how dysferlin deficiency initially results in the severe pathology of only specific muscles [1, 4]; consequently, no effective treatments are currently available for dysferlinopathy patients. This evidence concerns the gene DYSF and neuromuscular disease caused by qualitative or quantitative defects of dysferlin.